Furthermore, CAFs-Exo remarkably increased miR-1290, β-catenin, c-Myc and Cyclin D1 level and reduced GSK3β level in tumor tissues; however, these phenomena were all reversed by anti-miR-1290 treatment (Fig. 8F, G and Supplemental Material). The gene discussed is GSK3B; the disease is neoplasm.